Anthem Biosciences Ltd.

Research Anthem Biosciences Ltd. (ANTHEM.NS) on Bullrun: market cap INR 463.30B, P/E 81.0, dividend yield 0.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is INR 463.30B; P/E is 81.0; dividend yield is 0.2%.

Peer valuation comparison

Latest P/E is 81x versus a Healthcare sector median of 21.74x (272.5% above).

Latest dividend yield is 0.24% versus a Healthcare sector median of 2.4% (90.0% below).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18INR 463.30B81.00.2%2

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2 INR, yield 0.2%.

About Anthem Biosciences Ltd.

Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Anthem Biosciences Ltd.'s market cap?

Anthem Biosciences Ltd.'s market capitalization is INR 463.30B.

What is Anthem Biosciences Ltd.'s P/E ratio?

Anthem Biosciences Ltd.'s price-to-earnings (P/E) ratio is 81.0.

Does Anthem Biosciences Ltd. pay a dividend?

Anthem Biosciences Ltd. has a dividend yield of 0.2%.

What does Anthem Biosciences Ltd. do?

Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients.